MONHEIM, Germany, January 13, 2025 / Biotech Newswire / --

德国蒙海姆，2025年1月13日

Cube Biotech

Cube生物技术

and

和

IBA Lifesciences

IBA生活

, two leading innovators in the biotechnology industry, join forces to create a unified powerhouse dedicated to advancing research and production capabilities for the life science industry. The combined entity will leverage its complementary strengths to deliver unparalleled solutions in protein purification and stabilization and to enable groundbreaking research in the field of challenging drug targets..

。合并后的实体将利用其互补优势，在蛋白质纯化和稳定方面提供无与伦比的解决方案，并在具有挑战性的药物靶标领域进行开创性的研究。。

Cube Biotech's vision to accelerate innovation, simplify services, and broaden its global presence is reflected in the acquisition. Over the course of the last 12 months, the company has formed multiple collaborations to realize these goals. By combining Cube Biotech’s expertise in protein technologies with IBA Lifesciences strength in high performance research tools for protein isolation and analysis, the new entity is uniquely positioned to address the evolving needs of researchers and industry professionals worldwide..

Cube Biotech加速创新、简化服务和扩大全球影响力的愿景反映在此次收购中。在过去的12个月中，该公司为实现这些目标进行了多次合作。通过将Cube Biotech在蛋白质技术方面的专业知识与IBA Lifesciences在蛋白质分离和分析的高性能研究工具方面的优势相结合，该新实体具有独特的地位，可以满足全球研究人员和行业专业人员不断变化的需求。。

Strategic Highlights of the Acquisition:

收购的战略重点：

Didier Dargent, CEO of Cube Biotech, stated,

Cube Biotech首席执行官Didier Dargent表示，

“This acquisition marks an exciting new chapter for both companies. Together, we will harness our collective expertise to push the boundaries of what’s possible in the life sciences and enable researchers to make groundbreaking discoveries.”

Mike Rothe, CEO of IBA Lifesciences, added,

IBA Lifesciences首席执行官迈克·罗斯（MikeRothe）补充道，

“The fusion of our technologies and talents creates an outstanding foundation for innovation. Our combined efforts will benefit our customers and strengthen our position as leaders in the biotechnology market.”

“我们的技术和人才的融合为创新奠定了良好的基础。我们的共同努力将使我们的客户受益，并巩固我们在生物技术市场的领先地位。”

About

关于

Cube Biotech GmbH

Cube生物技术有限公司

Headquartered in Monheim, Germany, Cube Biotech is a leading provider of solutions for protein purification, stabilization, and structural studies. Known for its high-quality purification resins and membrane protein stabilization kits, Cube Biotech serves researchers across academia and industry. Cube Biotech is an ARCHIMED company since 2021..

Cube Biotech总部位于德国蒙海姆，是蛋白质纯化，稳定和结构研究解决方案的领先供应商。Cube Biotech以其高质量的纯化树脂和膜蛋白稳定试剂盒而闻名，为学术界和工业界的研究人员提供服务。Cube Biotech自2021年以来一直是一家架构良好的公司。。

About

关于

ARCHIMED

拱形

With offices in Europe, North America and Asia, ARCHIMED is a leading investment firm focused exclusively on healthcare industries. Its mix of operational, medical, scientific and financial expertise allows ARCHIMED to serve as both a strategic and financial partner to healthcare businesses. Prioritized areas of focus include Biopharma Products, Consumer Health, Healthcare IT, In Vitro Diagnostics, Life Science Tools & Biologic Services, MedTech, and Pharma Services.

ARCHIMED在欧洲、北美和亚洲设有办事处，是一家专注于医疗保健行业的领先投资公司。其综合了运营、医疗、科学和财务方面的专业知识，使ARCHIMED成为医疗保健业务的战略和财务合作伙伴。优先关注的领域包括生物制药产品、消费者健康、医疗保健IT、体外诊断、生命科学工具和生物服务、医疗技术和制药服务。

ARCHIMED helps partners internationalize, acquire, innovate and expand their products and services. ARCHIMED manages €8 billion across its various funds. Since inception, ARCHIMED has been a committed Impact investor, both directly and through its EURÊKA Foundation..

ARCHIMED帮助合作伙伴实现产品和服务的国际化、收购、创新和扩展。ARCHIMED管理着80亿欧元的各类基金。自成立以来，ARCHIMED一直是一家致力于影响力的投资者，无论是直接还是通过其EURÊKA基金会。。

About

关于

IBA Lifesciences GmbH

IBA生命科学有限公司

Based in Göttingen, Germany, IBA Lifesciences is renowned for its pioneering Strep-tag® system and innovative solutions in protein applications. With a strong focus on high-quality tools for biomolecular research, IBA Lifesciences has earned a global reputation for excellence.

IBA Lifesciences总部位于德国哥廷根，以其开创性的Strep tag®系统和蛋白质应用领域的创新解决方案而闻名。。

For more information about the acquisition or to speak with a representative, please contact:

有关收购的更多信息或与代表交谈，请联系：

Contact

联系人

Cube Biotech

Cube生物技术

Michael Ries

迈克尔·里斯

Head of Sales and Marketing

销售和市场营销主管

This email address is being protected from spambots. You need JavaScript enabled to view it.

此电子邮件地址受到垃圾邮件的保护。您需要启用JavaScript才能查看它。

Keywords: Drug Discovery; Proteins; Biological Science Disciplines; Cube Biotech;  IBA Lifesciences;  Membrane protein production;  Purification technologies;  Acquisition;  Monheim, Germany;  Göttingen, Germany;  Biotechnology industry;  Protein purification;  Protein stabilization;  Life science industry;  Protein technologies;  Research tools;  Protein isolation;  Protein analysis;  NativeMP platform;  Strep-tag® affinity technology;  Research and development;  Drug discovery value chain;  Didier Dargent;  Michael Ries;  Mike Rothe;  Strep-tag® system.

关键词：药物发现；蛋白质；生物科学学科；Cube生物技术；IBA生命科学；膜蛋白生产；净化技术；收购；德国蒙海姆；德国哥廷根；生物技术产业；蛋白质纯化；蛋白质稳定；生命科学产业；蛋白质技术；研究工具；蛋白质分离；蛋白质分析；；Strep tag®affinity技术；研究与开发；药物发现价值链；迪迪埃·达金特；迈克尔·里斯；迈克·罗斯；Strep tag®系统。

Source: Biotech Newswire

资料来源：Biotech Newswire